EyePoint Pharmaceuticals ...

NASDAQ: EYPT · Real-Time Price · USD
11.09
0.24 (2.21%)
At close: Aug 15, 2025, 3:59 PM
11.09
0.05%
After-hours: Aug 15, 2025, 04:10 PM EDT

EyePoint Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-130.87M -70.8M -102.25M -58.42M
Depreciation & Amortization
1.54M 464K 2.45M 2.77M
Stock-Based Compensation
36.74M 12.06M 14.18M 7.45M
Other Working Capital
-34.86M 44.48M -799K -959K
Other Non-Cash Items
-5.95M 1.18M 23.65M 628K
Deferred Income Tax
90K 83K n/a -787K
Change in Working Capital
-27.77M 58.88M -3.02M -1.74M
Operating Cash Flow
-126.23M 1.88M -65M -50.1M
Capital Expenditures
-4.05M -3.48M -2.15M -156K
Cash Acquisitions
n/a -168K -558K n/a
Purchase of Investments
-398.3M -55.12M -139.12M -32.97M
Sales Maturities Of Investments
177.05M 55.28M 124M n/a
Other Investing Acitivies
5.95M 168K 558K -32.97M
Investing Cash Flow
-219.35M -3.31M -17.27M -33.12M
Debt Repayment
-105K -40.51M 2.1M -146K
Common Stock Repurchased
n/a n/a -295K n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
813K 1.41M -3.19M 223K
Financial Cash Flow
164.02M 187.07M -690K 216.9M
Net Cash Flow
-181.56M 185.63M -82.96M 133.68M
Free Cash Flow
-130.28M -1.61M -67.16M -50.25M